Navigation Links
Cumberland Pharmaceuticals Reports 2011 Annual Financial Results
Date:2/29/2012

1)(768,642)(712,343)Cash flows from financing activities:Proceeds from initial public offering of common stock--85,000,000Costs of initial public offering--(7,479,011)Proceeds from borrowings on long-term debt--18,000,000Principal payments on note payable(5,333,333)(12,666,667)(5,000,000)Net borrowings on line of credit3,034,000--Costs of financing for long-term debt and credit facility(17,637)(110,000)(189,660)Payments made in connection with repurchase of common shares(4,247,440)(4,846,791)(27,295,808)Proceeds from exercise of stock options629,8651,362,760175,089Excess tax benefit derived from exercise of stock options2,355,3453,874,9663,968,894Net cash (used in) provided by financing activities(3,579,200)(12,385,732)67,179,504Net increase (decrease) in cash and cash equivalents4,705,176(12,807,712)66,872,131Cash and cash equivalents, beginning of year65,893,97078,701,68211,829,551Cash and cash equivalents, end of year$   70,599,146$   65,893,970$   78,701,682Supplemental disclosure of cash flow information:Cash paid during the year for:Interest$
91,410$
814,373$
77,387Income taxes304,48052,136196,187Noncash investing and financing activities:Change in unpaid invoices for purchases of intangibles97,806--Reclass of redeemable common stock to (from) equity-1,930,000(1,930,000)Deferred financing costs--335,075
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
5. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
6. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... analysis of Centers for Medicare and Medicaid Services, (CMS) ... percent of seniors chose lower-cost preferred pharmacy plans that ... The findings were released by Drug Channels . ... of Medicare Part D," said Pharmaceutical Care Management Association ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. ... Biotechnology, Inc. for the compounding, packaging and distributing of its ... the United States . ... of compounding naltrexone tablets in various strengths for individual patients ...
(Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... of medical devices worldwide, announced today an agreement to ... Technical Development Co. Ltd. The terms of the transaction ... Mindray,s financial statements. Founded in 2004 and ...
... Nev., Feb. 28, 2011 PDL ... financial results for the fourth quarter and full year ended ... were $345.0 million, compared to $318.2 million in 2009.  Excluding ... royalty revenues for 2010 increased 30 percent over 2009.  For ...
Cached Medicine Technology:Mindray Medical to Acquire a Controlling Stake in Shenke Medical 2Mindray Medical to Acquire a Controlling Stake in Shenke Medical 3Mindray Medical to Acquire a Controlling Stake in Shenke Medical 4PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 2PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 3PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 4PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 5PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 6PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 7PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 8PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 9PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results 10
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... an effort to further promote visibility and adoption of the ... made AMA journals available via its subscription services, EBSCO will ... , Long known as both a subscription agency ...
(Date:1/22/2015)... 2015 Step into a macabre world ... Museum of Virginia. Wicked Plants, the Museum’s latest featured ... 75 poisonous, carnivorous and diabolical plants inside of a ... uncover the biochemical, physical and neurological processes between botanicals ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... , NEW YORK, Sept. 10 , , , What: ... Americans could come down with the swine flu this fall and, ... by July, more, than a ... hospitalized. With fears that swine flu will become a, ...
... , , ST. LOUIS, ... management, business intelligence and performance management solutions announced that ... portal for BlueAdvantage Administrators of Arkansas to enable greater ... The intranet portal will provide BlueAdvantage employees the ability ...
... OIG Report Indicates Attention to Compliance Issues is ... 10 Yesterday, the Department of Health and Human Services Office ... series of four, which reviewed the hospice benefit for residents of ... claims that were part of the study did not meet at ...
... , , KANSAS CITY, Mo., Sept. 10 ... a treatment and cure for polycystic kidney disease (PKD), a genetic ... may be put on hold if fundraising efforts continue to fall ... event. , , The Walk for PKD, held ...
... , , , ... :PRX) today announced that it has received final approval from the ... for nateglinide tablets. Nateglinide is a generic version of Novartis, ... according to IMS Health data. Par will begin shipping the ...
... In the news release, "First Results From Major European ... issued on 9,Sep 2009 07:00 GMT, by Nycomed over PR ... the first set of bullet points should read,"The median number ... episode,had a median duration of 60 minutes; 96% of the ...
Cached Medicine News:Health News:Insite Security Hosts Webinar on Swine Flu Preparedness 2Health News:Amitech Solutions Selected to Implement SharePoint Portal for BlueAdvantage Administrators of Arkansas 2Health News:Amitech Solutions Selected to Implement SharePoint Portal for BlueAdvantage Administrators of Arkansas 3Health News:NHPCO Working to Help Hospices With Compliance for Hospice Patients in Nursing Homes 2Health News:NHPCO Working to Help Hospices With Compliance for Hospice Patients in Nursing Homes 3Health News:Success of National Fundraising Event Critical to Promising Research for Life-Threatening Kidney Disease 2Health News:Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R) 2Health News:/C O R R E C T I O N -- Nycomed/ 2Health News:/C O R R E C T I O N -- Nycomed/ 3Health News:/C O R R E C T I O N -- Nycomed/ 4Health News:/C O R R E C T I O N -- Nycomed/ 5Health News:/C O R R E C T I O N -- Nycomed/ 6Health News:/C O R R E C T I O N -- Nycomed/ 7
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
... tricompartmental total knee prosthesis stems from many ... design and manufacturing technologies have been used ... as well as a favorable pressure distribution ... keep wear to a minimum. The inherent ...
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
Medicine Products: